K M C Speciality Hospitals (India) growth ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY24Mar 2024FY23Mar 2023FY22Mar 2022FY20 and earlierAlpha Plus
+13.8%+14.5%+32.6%
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
+14.7%+11.1%+60.0%
+13.3%+9.9%+79.5%
+13.8%+12.5%+85.7%
+13.4%+13.1%+85.9%
—+41.1%+22.6%
——+13.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Revenue Growth—+32.6+14.5+13.8
EBITDA Growth—+60.0+11.1+14.7
EBIT Growth—+79.5+9.9+13.3
Net Income Growth—+85.7+12.5+13.8
EPS Growth—+85.9+13.1+13.4
Total Assets Growth—+22.6+41.1—
Cash from Operations Growth—+13.7——
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.